Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 3/20 | 0.36 |
| ▸ | ANPEP | P15144 | 3/20 | 0.36 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.35 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.33 |
| ▸ | SCN9A | Q15858 | 7/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.31 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.31 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.31 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.31 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.31 |
| ▸ | DRD1 | P21728 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25868446 | 0.96 | ANPEP (0.36) | DPP4ANPEPNR1H2NR1H3PTGS2 | |
| SCHEMBL25868265 | 0.96 | DPP4 (0.39) | DPP4ANPEPNR1H2NR1H3PTGS2 | |
| SCHEMBL25868502 | 0.94 | DPP4 (0.40) | DPP4ANPEPNR1H2NR1H3PTGS2 | |
| SCHEMBL25868427 | 0.93 | ANPEP (0.37) | DPP4ANPEPNR1H2NR1H3PTGS2 | |
| SCHEMBL25868146 | 0.92 | ANPEP (0.38) | DPP4ANPEPNR1H2NR1H3PTGS2 | |
| SCHEMBL25868289 | 0.92 | DPP4 (0.38) | DPP4ANPEPNR1H2NR1H3PTGS2 | |
| SCHEMBL25871350 | 0.92 | ANPEP (0.42) | DPP4ANPEPNR1H2NR1H3CA12 | |
| SCHEMBL25868455 | 0.91 | ANPEP (0.35) | DPP4ANPEPNR1H2NR1H3PTGS2 | |
| SCHEMBL25868403 | 0.89 | PDCD1 (0.32) | DPP4ANPEPNR1H2NR1H3SCN9A | |
| SCHEMBL25868398 | 0.89 | ANPEP (0.39) | DPP4ANPEPNR1H2NR1H3SCN9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230235217-A1 | LUMINESCENT COMPOUND, METHOD FOR PRODUCING LUMINESCENT COMPOUND, LUMINESCENT COMPOSITION, LUMINESCENT THIN FILM AND LUMINESCENT PARTICLES | Konica Minolta, Inc. (JP) | 2023-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230235217-A1 | LUMINESCENT COMPOUND, METHOD FOR PRODUCING LUMINESCENT COMPOUND, LUMINESCENT COMPOSITION, LUMINESCENT THIN FILM AND LUMINESCENT PARTICLES | SCLY, SOD1, GPX1 | DPP4 3835/4885ANPEP 4600/4885NR1H2 1676/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.